Following a massive cyberattack in 2023 and a related lawsuit settlement, 23andMe filed for bankruptcy in March, with Wojcicki resigning in order to become an independent bidder for the company. But pharmaceutical company Regeneron was announced as the company's acquirer with a $256 million bid. According to the Wall Street Journal, Wojcicki's nonprofit TTAM Research Institute reopened the bidding process by making an unsolicited bid earlier this month, and Regeneron declined to beat TTAM's $305 million offer. In the announcement, TTAM (an acronym that corresponds with the first letters of Twenty-Three And Me) said that customers will be notified of the acquisition at least two business deals before the deal closes, and that the nonprofit will continue to abide by 23andMe's privacy policies allowing customers to delete their data and opt-out of research. It also said that it will establish a Consumer Privacy Advisory Board within 90 days of closing. 'I am thrilled that TTAM Research...
learn more
